Zobrazeno 1 - 10
of 120
pro vyhledávání: '"anti-PF4"'
Autor:
Abraham Attah, Chelsea Peterson, Max Jacobs, Rama Bhagavatula, Deep Shah, Robert Kaplan, Yazan Samhouri
Publikováno v:
Hematology Reports, Vol 16, Iss 2, Pp 295-298 (2024)
Heparin products are frequently used in the inpatient setting to prevent and treat venous thromboembolism, but they simultaneously put patients at risk of developing heparin-induced thrombocytopenia (HIT). The 4Ts score determines the pretest probabi
Externí odkaz:
https://doaj.org/article/7f9b606fcb1c4031b6599ae8d87d23b8
Autor:
Shweta Parakh, Shrey Maheshwari, Shrutanjoy Das, Hans Vaish, Gaurav Luthra, Rupesh Agrawal, Vishali Gupta, Saurabh Luthra
Publikováno v:
Journal of Ophthalmic Inflammation and Infection, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Purpose To report a case of central retinal vein occlusion (CRVO) seven days following the first dose of ChAdOx1 nCoV-19 vaccine and propose a hypothesis for the possible underlying pathogenesis. Observation A 31-year-old male presented with
Externí odkaz:
https://doaj.org/article/8f64306bae994161a0dea3537f07601f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Luca Barcella, Chiara Ambaglio, Paolo Gritti, Francesca Schieppati, Varusca Brusegan, Eleonora Sanga, Marina Marchetti, Luca Lorini, Anna Falanga
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 2, Iss 2 (2023)
A syndrome occurring after adenoviral vector anti-SARS-CoV-2 vaccination, characterized by thrombocytopenia, venous thrombosis, and circulating anti-PF4 antibodies, known as vaccine-induced immune thrombotic thrombocytopenia (VITT), is well described
Externí odkaz:
https://doaj.org/article/81b15c434ca04a57ad38affcbd9e5ba6
Autor:
Daniela P. Mendes-de-Almeida, Fernanda S. G. Kehdy, Remy Martins-Gonçalves, Joanna Bokel, Eduarda Grinsztejn, Patrícia Mouta Nunes de Oliveira, Maria de Lourdes de Sousa Maia, Brenda Hoagland, Sandra Wagner Cardoso, Beatriz Grinsztejn, Marilda M. Siqueira, Pedro Kurtz, Patricia T. Bozza, Cristiana C. Garcia
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
The emergence of the rare syndrome called vaccine-induced immune thrombocytopenia and thrombosis (VITT) after adenoviral vector vaccines, including ChAdOx1 nCov-19, raises concern about one's predisposing risk factors. Here we report the case of a 56
Externí odkaz:
https://doaj.org/article/ba389ae50dfb4ddc9339e1bb0fea71c9
Autor:
Atyabi Seyed Mohammad Hassan, Rommasi Foad, Ramezani Mohammad Hossein, Ghane Ezabadi Mohammad Fazel, Arani Mehdi AghaAmooi, Sadeghi Mohammad Hossein, Ahmed Mohammad Mehdi, Rajabi Amir, Dehghan Nima, Sohrabi Ali, Seifi Mojtaba, Nasiri Mohammad Javad
Publikováno v:
Open Life Sciences, Vol 17, Iss 1, Pp 401-415 (2022)
SARS-CoV-2 pandemic is one of the most critical pandemics during human civilization. Several therapeutic strategies for COVID-19 management have been offered; nonetheless, none of them seems to be sufficiently beneficial. In effect, vaccines have bee
Externí odkaz:
https://doaj.org/article/106540961ce54e2bb0c3d123db08c861
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Negar Mottaghi Dastgerdi, Homa Faghihi
Publikováno v:
Research in Molecular Medicine, Vol 9, Iss 4, Pp 221-228 (2021)
Background: ChAdOx1 nCov-19 vaccine is a viral vector-based vaccine with desirable protection (about 70.4%, two weeks after the second dose). Few reports were released on thrombocytopenia associated with thrombotic events shortly after the ChAdOx1 nC
Externí odkaz:
https://doaj.org/article/eb54bede0a404c67a273564c10a67aac
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Samantha J. Montague, Christopher W. Smith, Clare S. Lodwick, Charlotte Stoneley, Matthew Roberts, Gillian C. Lowe, William A. Lester, Steve P. Watson, Phillip L. R. Nicolson
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 3, Pp n/a-n/a (2022)
Abstract Background Anti‐platelet factor 4 (PF4) antibodies that activate platelets via FcγRIIA drive the pathophysiology of vaccine‐induced immune thrombocytopenia and thrombosis (VITT). Evolution of these antibodies and their ability to activa
Externí odkaz:
https://doaj.org/article/66bf351f0ec74913826ce427be977694